Patents by Inventor Tadas Vasaitis

Tadas Vasaitis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Androgen receptor down-regulating agents and uses thereof
    Patent number: 9884067
    Abstract: The present disclosure provides the design and synthesis of novel steroidal compounds that cause down-regulation of the androgen receptor (AR), both full length and splice variant. The compounds are potential agents for the treatment of all forms of prostate cancer and other diseases that depend on functional AR.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: February 6, 2018
    Assignees: University of Maryland, Baltimore, University of Maryland Eastern Shore, Thomas Jefferson University
    Inventors: Vincent C. O. Njar, Lalji K. Gediya, Puranik Purushottamachar, Abhijit Godbole, Andrew Kwegyir-Afful, Tadas Vasaitis
  • Androgen receptor down-regulating agents and uses thereof
    Patent number: 9439912
    Abstract: The present disclosure provides the design and synthesis of novel steroidal compounds that cause down-regulation of the androgen receptor (AR), both full length and splice variant. The compounds are potential agents for the treatment of all forms of prostate cancer and other diseases that depend on functional AR.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: September 13, 2016
    Assignee: University of Maryland, Baltimore
    Inventors: Vincent C. O. Njar, Lalji K. Gediya, Puranik Purushottamachar, Abhijit Godbole, Andrew Kwegyir-Afful, Tadas Vasaitis
  • ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF
    Publication number: 20160000808
    Abstract: The present disclosure provides the design and synthesis of novel steroidal compounds that cause down-regulation of the androgen receptor (AR), both full length and splice variant. The compounds are potential agents for the treatment of all forms of prostate cancer and other diseases that depend on functional AR.
    Type: Application
    Filed: July 8, 2015
    Publication date: January 7, 2016
    Inventors: Vincent C.O. Njar, Lalji K. Gediya, Puranik Purushottamachar, Abhijit Godbole, Andrew Kwegyir-Afful, Tadas Vasaitis
  • ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF
    Publication number: 20150361126
    Abstract: The present disclosure provides the design and synthesis of novel steroidal compounds that cause down-regulation of the androgen receptor (AR), both full length and splice variant. The compounds are potential agents for the treatment of all forms of prostate cancer and other diseases that depend on functional AR.
    Type: Application
    Filed: March 14, 2014
    Publication date: December 17, 2015
    Inventors: Vincent C.O. Njar, Lalji K. Gediya, Puranik Purushottamachar, Abhijit Godbole, Andrew Kwegyir-Afful, Tadas Vasaitis